Literature DB >> 7438041

Production of Nb rat carcinoma of the dorsal prostate and response of estrogen-dependent transplants to sex hormones and tamoxifen.

R L Noble.   

Abstract

Carcinoma in the dorsal prostate of Nb rats was produced by prolonged treatment with androgen or androgen plus estrogen. The most effective combination was androgen followed by estrogen, resulting in an incidence of 50% in 10 rats. In such a case, the rats did not show evidence of androgenization. Transplants were usually not sensitive to hormones, but an estrogen-dependent tumor (Nb-2Pr-E) was successfully transplanted in estrogenized hosts. Cells of estrogen-dependent tumors did not grow in males but remained dormant and could be stimulated to grow after many months by estrogen treatment. The resulting tumors remained estrogen dependent, with one exception which was autonomous. Tumors regressed following estrogen removal but eventually showed a spontaneous regrowth which was then found to be autonomous. In the case of growing tumors, the reduction of estrogen to subthreshold doses for maximal growth allowed stationary or only slow growth of the tumors, but these remained estrogen dependent. Estrogen-dependent tumors responded to tamoxifen treatment by a cessation of tumor growth or regression despite continued estrogen treatment. Tumor regrowth eventually took place after prolonged tamoxifen treatment, but the tumors remained estrogen dependent when transplanted.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7438041

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

Review 1.  The other side of the coin: the tumor-suppressive aspect of oncogenes and the oncogenic aspect of tumor-suppressive genes, such as those along the CCND-CDK4/6-RB axis.

Authors:  Xiaomin Lou; Ju Zhang; Siqi Liu; Ningzhi Xu; D Joshua Liao
Journal:  Cell Cycle       Date:  2014-05-05       Impact factor: 4.534

2.  Estrogen-initiated transformation of prostate epithelium derived from normal human prostate stem-progenitor cells.

Authors:  Wen-Yang Hu; Guang-Bin Shi; Hung-Ming Lam; Dan-Ping Hu; Shuk-Mei Ho; Ikenna C Madueke; Andre Kajdacsy-Balla; Gail S Prins
Journal:  Endocrinology       Date:  2011-03-22       Impact factor: 4.736

3.  Establishment and control of the L5178Y-cell tumor dormant state in DBA/2 mice.

Authors:  E F Wheelock; M K Robinson; G A Truitt
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

4.  Control of growth in the rat thyroid--an example of specific desensitization to trophic hormone stimulation.

Authors:  D Wynford-Thomas; B M Stringer; H R Harach; E D Williams
Journal:  Experientia       Date:  1983-04-15

5.  A novel role for raloxifene nanomicelles in management of castrate resistant prostate cancer.

Authors:  Sebastien Taurin; Hayley Nehoff; Thalita van Aswegen; Rhonda J Rosengren; Khaled Greish
Journal:  Biomed Res Int       Date:  2014-02-06       Impact factor: 3.411

6.  Just like the rest of evolution in Mother Nature, the evolution of cancers may be driven by natural selection, and not by haphazard mutations.

Authors:  Ju Zhang; Xiaomin Lou; Lucas Zellmer; Siqi Liu; Ningzhi Xu; D Joshua Liao
Journal:  Oncoscience       Date:  2014-09-22

Review 7.  Importance of Estrogenic Signaling and Its Mediated Receptors in Prostate Cancer.

Authors:  Kin-Mang Lau; Ka-Fai To
Journal:  Int J Mol Sci       Date:  2016-08-31       Impact factor: 5.923

Review 8.  Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine.

Authors:  Tetsuya Fujimura; Kenichi Takayama; Satoru Takahashi; Satoshi Inoue
Journal:  Cancers (Basel)       Date:  2018-01-23       Impact factor: 6.639

Review 9.  Weaknesses and Pitfalls of Using Mice and Rats in Cancer Chemoprevention Studies.

Authors:  Yukui Ma; Yuping Jia; Lichan Chen; Lewis Ezeogu; Baofa Yu; Ningzhi Xu; D Joshua Liao
Journal:  J Cancer       Date:  2015-09-01       Impact factor: 4.207

Review 10.  Role of the adjacent stroma cells in prostate cancer development and progression: synergy between TGF-β and IGF signaling.

Authors:  Chung Lee; Zhenyu Jia; Farah Rahmatpanah; Qiang Zhang; Xiaolin Zi; Michael McClelland; Dan Mercola
Journal:  Biomed Res Int       Date:  2014-06-25       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.